Drug Trial Radar · NCT03440372
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Last checked: Nov 20, 2026Latest source record: Nov 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
625
Actual
Start
Feb 27, 2018
Primary completion
Oct 1, 2024
Study completion Oct 1, 2024
Sponsor
- Lead sponsor
- CelgeneBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Feb 22, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.
Conditions
- Crohn Disease
Interventions
OzanimodDrug
Specified dose on specified days
PlaceboOther
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of Participants With a Crohn's Disease Activity Index (CDAI) Score < 150 at Week 12Time frame: At Week 12
Locations
408 sites in 35 countries. Site status is shown where the registry gives one.
Holland Center for Family Health
Peoria, Arizona
Local Institution - 026
North Little Rock, Arkansas
Local Institution - 284
Camarillo, California
Local Institution - 165
Chula Vista, California
Local Institution - 039
Garden Grove, California
San Diego Clinical Trials
La Mesa, California
Local Institution - 061
Los Angeles, California
Local Institution - 110
Los Angeles, California
Local Institution - 140
Mission Viejo, California
Alliance Clinical Research
Oceanside, California
Local Institution - 027
Orange, California
Palo Alto Center-Palo Alto Medical Foundation Research Institute
Palo Alto, California
Local Institution - 006
Rialto, California
Local Institution - 003
San Diego, California
Local Institution - 297
Lakewood, Colorado
Local Institution - 225
Bristol, Connecticut
Local Institution - 091
New Haven, Connecticut
Local Institution - 062
Clearwater, Florida
Local Institution - 218
Gainesville, Florida
Local Institution - 203
Hialeah, Florida
Harmony Medical Research Institute
Hialeah, Florida
Local Institution - 078
Hialeah, Florida
Local Institution - 179
Hollywood, Florida
Local Institution - 101
Homestead, Florida
Local Institution - 016
Largo, Florida
Local Institution - 199
Miami, Florida
LCC Medical Research Institute, LLC
Miami, Florida
Local Institution - 169
Miami, Florida
Local Institution - 090
Naples, Florida
Local Institution - 214
New Smyrna Beach, Florida
Local Institution - 076
Orlando, Florida
Local Institution - 098
Port Orange, Florida
Local Institution - 226
Tampa, Florida
Local Institution - 149
Tampa, Florida
Local Institution - 114
Weeki Wachee, Florida
Local Institution - 205
Atlanta, Georgia
Local Institution - 222
Atlanta, Georgia
Local Institution - 019
Atlanta, Georgia
Local Institution - 063
Atlanta, Georgia
Local Institution - 074
Columbus, Georgia
Showing 40 of 408 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.